Global and United States Disease Control and Prevention Vaccine Market Report & Forecast 2022-2028

Global and United States Disease Control and Prevention Vaccine Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Disease Control and Prevention Vaccine Product Introduction
1.2 Global Disease Control and Prevention Vaccine Outlook 2017 VS 2022 VS 2028
1.2.1 Global Disease Control and Prevention Vaccine Sales in US$ Million for the Year 2017-2028
1.2.2 Global Disease Control and Prevention Vaccine Sales in Volume for the Year 2017-2028
1.3 United States Disease Control and Prevention Vaccine Outlook 2017 VS 2022 VS 2028
1.3.1 United States Disease Control and Prevention Vaccine Sales in US$ Million for the Year 2017-2028
1.3.2 United States Disease Control and Prevention Vaccine Sales in Volume for the Year 2017-2028
1.4 Disease Control and Prevention Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Disease Control and Prevention Vaccine in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Disease Control and Prevention Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Disease Control and Prevention Vaccine Market Dynamics
1.5.1 Disease Control and Prevention Vaccine Industry Trends
1.5.2 Disease Control and Prevention Vaccine Market Drivers
1.5.3 Disease Control and Prevention Vaccine Market Challenges
1.5.4 Disease Control and Prevention Vaccine Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Disease Control and Prevention Vaccine Market Segment by Type
2.1.1 Live-Attenuated
2.1.2 Inactivated
2.1.3 Recombinant Sub Unit and Toxoid
2.2 Global Disease Control and Prevention Vaccine Market Size by Type
2.2.1 Global Disease Control and Prevention Vaccine Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Disease Control and Prevention Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Disease Control and Prevention Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Disease Control and Prevention Vaccine Market Size by Type
2.3.1 United States Disease Control and Prevention Vaccine Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Disease Control and Prevention Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Disease Control and Prevention Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Disease Control and Prevention Vaccine Market Segment by Application
3.1.1 Pediatric Vaccine
3.1.2 Adult Vaccine
3.2 Global Disease Control and Prevention Vaccine Market Size by Application
3.2.1 Global Disease Control and Prevention Vaccine Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Disease Control and Prevention Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Disease Control and Prevention Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Disease Control and Prevention Vaccine Market Size by Application
3.3.1 United States Disease Control and Prevention Vaccine Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Disease Control and Prevention Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Disease Control and Prevention Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Disease Control and Prevention Vaccine Competitor Landscape by Company
4.1 Global Disease Control and Prevention Vaccine Market Size by Company
4.1.1 Top Global Disease Control and Prevention Vaccine Manufacturers Ranked by Revenue (2021)
4.1.2 Global Disease Control and Prevention Vaccine Revenue by Manufacturer (2017-2022)
4.1.3 Global Disease Control and Prevention Vaccine Sales by Manufacturer (2017-2022)
4.1.4 Global Disease Control and Prevention Vaccine Price by Manufacturer (2017-2022)
4.2 Global Disease Control and Prevention Vaccine Concentration Ratio (CR)
4.2.1 Disease Control and Prevention Vaccine Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Disease Control and Prevention Vaccine in 2021
4.2.3 Global Disease Control and Prevention Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Disease Control and Prevention Vaccine Manufacturing Base Distribution, Product Type
4.3.1 Global Disease Control and Prevention Vaccine Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Disease Control and Prevention Vaccine Product Type
4.3.3 Date of International Manufacturers Enter into Disease Control and Prevention Vaccine Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Disease Control and Prevention Vaccine Market Size by Company
4.5.1 Top Disease Control and Prevention Vaccine Players in United States, Ranked by Revenue (2021)
4.5.2 United States Disease Control and Prevention Vaccine Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Disease Control and Prevention Vaccine Sales by Players (2020, 2021 & 2022)
5 Global Disease Control and Prevention Vaccine Market Size by Region
5.1 Global Disease Control and Prevention Vaccine Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Disease Control and Prevention Vaccine Market Size in Volume by Region (2017-2028)
5.2.1 Global Disease Control and Prevention Vaccine Sales in Volume by Region: 2017-2022
5.2.2 Global Disease Control and Prevention Vaccine Sales in Volume Forecast by Region (2023-2028)
5.3 Global Disease Control and Prevention Vaccine Market Size in Value by Region (2017-2028)
5.3.1 Global Disease Control and Prevention Vaccine Sales in Value by Region: 2017-2022
5.3.2 Global Disease Control and Prevention Vaccine Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Disease Control and Prevention Vaccine Market Size YoY Growth 2017-2028
6.1.2 North America Disease Control and Prevention Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Disease Control and Prevention Vaccine Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Disease Control and Prevention Vaccine Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Disease Control and Prevention Vaccine Market Size YoY Growth 2017-2028
6.3.2 Europe Disease Control and Prevention Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Disease Control and Prevention Vaccine Market Size YoY Growth 2017-2028
6.4.2 Latin America Disease Control and Prevention Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Disease Control and Prevention Vaccine Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Disease Control and Prevention Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 GSK
7.1.1 GSK Corporation Information
7.1.2 GSK Description and Business Overview
7.1.3 GSK Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.1.4 GSK Disease Control and Prevention Vaccine Products Offered
7.1.5 GSK Recent Development
7.2 Merck & Co., Inc
7.2.1 Merck & Co., Inc Corporation Information
7.2.2 Merck & Co., Inc Description and Business Overview
7.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Merck & Co., Inc Disease Control and Prevention Vaccine Products Offered
7.2.5 Merck & Co., Inc Recent Development
7.3 Pfizer
7.3.1 Pfizer Corporation Information
7.3.2 Pfizer Description and Business Overview
7.3.3 Pfizer Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Pfizer Disease Control and Prevention Vaccine Products Offered
7.3.5 Pfizer Recent Development
7.4 Sanofi
7.4.1 Sanofi Corporation Information
7.4.2 Sanofi Description and Business Overview
7.4.3 Sanofi Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Sanofi Disease Control and Prevention Vaccine Products Offered
7.4.5 Sanofi Recent Development
7.5 AstraZeneca PLC
7.5.1 AstraZeneca PLC Corporation Information
7.5.2 AstraZeneca PLC Description and Business Overview
7.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.5.4 AstraZeneca PLC Disease Control and Prevention Vaccine Products Offered
7.5.5 AstraZeneca PLC Recent Development
7.6 Sinovac Biotech Ltd
7.6.1 Sinovac Biotech Ltd Corporation Information
7.6.2 Sinovac Biotech Ltd Description and Business Overview
7.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Products Offered
7.6.5 Sinovac Biotech Ltd Recent Development
7.7 Astellas Pharma Inc
7.7.1 Astellas Pharma Inc Corporation Information
7.7.2 Astellas Pharma Inc Description and Business Overview
7.7.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Astellas Pharma Inc Disease Control and Prevention Vaccine Products Offered
7.7.5 Astellas Pharma Inc Recent Development
7.8 Serum Institute of India Pvt. Ltd
7.8.1 Serum Institute of India Pvt. Ltd Corporation Information
7.8.2 Serum Institute of India Pvt. Ltd Description and Business Overview
7.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Products Offered
7.8.5 Serum Institute of India Pvt. Ltd Recent Development
7.9 Daiichi Sankyo
7.9.1 Daiichi Sankyo Corporation Information
7.9.2 Daiichi Sankyo Description and Business Overview
7.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Daiichi Sankyo Disease Control and Prevention Vaccine Products Offered
7.9.5 Daiichi Sankyo Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Disease Control and Prevention Vaccine Industry Chain Analysis
8.2 Disease Control and Prevention Vaccine Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Disease Control and Prevention Vaccine Distributors
8.3 Disease Control and Prevention Vaccine Production Mode & Process
8.4 Disease Control and Prevention Vaccine Sales and Marketing
8.4.1 Disease Control and Prevention Vaccine Sales Channels
8.4.2 Disease Control and Prevention Vaccine Distributors
8.5 Disease Control and Prevention Vaccine Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Disease Control and Prevention Vaccine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Disease Control and Prevention Vaccine Market Trends
Table 3. Disease Control and Prevention Vaccine Market Drivers
Table 4. Disease Control and Prevention Vaccine Market Challenges
Table 5. Disease Control and Prevention Vaccine Market Restraints
Table 6. Global Disease Control and Prevention Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Disease Control and Prevention Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Disease Control and Prevention Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Disease Control and Prevention Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Disease Control and Prevention Vaccine Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Disease Control and Prevention Vaccine Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Disease Control and Prevention Vaccine Revenue Share by Manufacturer, 2017-2022
Table 13. Global Disease Control and Prevention Vaccine Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Disease Control and Prevention Vaccine Sales Share by Manufacturer, 2017-2022
Table 15. Global Disease Control and Prevention Vaccine Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Disease Control and Prevention Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Disease Control and Prevention Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Disease Control and Prevention Vaccine as of 2021)
Table 18. Top Players of Disease Control and Prevention Vaccine in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Disease Control and Prevention Vaccine Product Type
Table 20. Date of International Manufacturers Enter into Disease Control and Prevention Vaccine Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Disease Control and Prevention Vaccine Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Disease Control and Prevention Vaccine Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Disease Control and Prevention Vaccine Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Disease Control and Prevention Vaccine Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Disease Control and Prevention Vaccine Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Disease Control and Prevention Vaccine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Disease Control and Prevention Vaccine Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Disease Control and Prevention Vaccine Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Disease Control and Prevention Vaccine Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Disease Control and Prevention Vaccine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Disease Control and Prevention Vaccine Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Disease Control and Prevention Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Disease Control and Prevention Vaccine Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Disease Control and Prevention Vaccine Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Disease Control and Prevention Vaccine Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Disease Control and Prevention Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Disease Control and Prevention Vaccine Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Disease Control and Prevention Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Disease Control and Prevention Vaccine Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Disease Control and Prevention Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. GSK Corporation Information
Table 43. GSK Description and Business Overview
Table 44. GSK Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. GSK Disease Control and Prevention Vaccine Product
Table 46. GSK Recent Development
Table 47. Merck & Co., Inc Corporation Information
Table 48. Merck & Co., Inc Description and Business Overview
Table 49. Merck & Co., Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Merck & Co., Inc Product
Table 51. Merck & Co., Inc Recent Development
Table 52. Pfizer Corporation Information
Table 53. Pfizer Description and Business Overview
Table 54. Pfizer Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Pfizer Product
Table 56. Pfizer Recent Development
Table 57. Sanofi Corporation Information
Table 58. Sanofi Description and Business Overview
Table 59. Sanofi Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Sanofi Product
Table 61. Sanofi Recent Development
Table 62. AstraZeneca PLC Corporation Information
Table 63. AstraZeneca PLC Description and Business Overview
Table 64. AstraZeneca PLC Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. AstraZeneca PLC Product
Table 66. AstraZeneca PLC Recent Development
Table 67. Sinovac Biotech Ltd Corporation Information
Table 68. Sinovac Biotech Ltd Description and Business Overview
Table 69. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Sinovac Biotech Ltd Product
Table 71. Sinovac Biotech Ltd Recent Development
Table 72. Astellas Pharma Inc Corporation Information
Table 73. Astellas Pharma Inc Description and Business Overview
Table 74. Astellas Pharma Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Astellas Pharma Inc Product
Table 76. Astellas Pharma Inc Recent Development
Table 77. Serum Institute of India Pvt. Ltd Corporation Information
Table 78. Serum Institute of India Pvt. Ltd Description and Business Overview
Table 79. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Serum Institute of India Pvt. Ltd Product
Table 81. Serum Institute of India Pvt. Ltd Recent Development
Table 82. Daiichi Sankyo Corporation Information
Table 83. Daiichi Sankyo Description and Business Overview
Table 84. Daiichi Sankyo Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Daiichi Sankyo Product
Table 86. Daiichi Sankyo Recent Development
Table 87. Key Raw Materials Lists
Table 88. Raw Materials Key Suppliers Lists
Table 89. Disease Control and Prevention Vaccine Customers List
Table 90. Disease Control and Prevention Vaccine Distributors List
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Disease Control and Prevention Vaccine Product Picture
Figure 2. Global Disease Control and Prevention Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Disease Control and Prevention Vaccine Market Size 2017-2028 (US$ Million)
Figure 4. Global Disease Control and Prevention Vaccine Sales 2017-2028 (K Units)
Figure 5. United States Disease Control and Prevention Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Disease Control and Prevention Vaccine Market Size 2017-2028 (US$ Million)
Figure 7. United States Disease Control and Prevention Vaccine Sales 2017-2028 (K Units)
Figure 8. United States Disease Control and Prevention Vaccine Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Disease Control and Prevention Vaccine Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Disease Control and Prevention Vaccine Report Years Considered
Figure 11. Product Picture of Live-Attenuated
Figure 12. Product Picture of Inactivated
Figure 13. Product Picture of Recombinant Sub Unit and Toxoid
Figure 14. Global Disease Control and Prevention Vaccine Market Share by Type in 2022 & 2028
Figure 15. Global Disease Control and Prevention Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Disease Control and Prevention Vaccine Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Disease Control and Prevention Vaccine Sales by Type (2017-2028) & (K Units)
Figure 18. Global Disease Control and Prevention Vaccine Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Disease Control and Prevention Vaccine Price by Type (2017-2028) & (USD/Unit)
Figure 20. United States Disease Control and Prevention Vaccine Market Share by Type in 2022 & 2028
Figure 21. United States Disease Control and Prevention Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Disease Control and Prevention Vaccine Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Disease Control and Prevention Vaccine Sales by Type (2017-2028) & (K Units)
Figure 24. United States Disease Control and Prevention Vaccine Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Disease Control and Prevention Vaccine Price by Type (2017-2028) & (USD/Unit)
Figure 26. Product Picture of Pediatric Vaccine
Figure 27. Product Picture of Adult Vaccine
Figure 28. Global Disease Control and Prevention Vaccine Market Share by Application in 2022 & 2028
Figure 29. Global Disease Control and Prevention Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global Disease Control and Prevention Vaccine Sales Market Share in Value by Application (2017-2028)
Figure 31. Global Disease Control and Prevention Vaccine Sales by Application (2017-2028) & (K Units)
Figure 32. Global Disease Control and Prevention Vaccine Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global Disease Control and Prevention Vaccine Price by Application (2017-2028) & (USD/Unit)
Figure 34. United States Disease Control and Prevention Vaccine Market Share by Application in 2022 & 2028
Figure 35. United States Disease Control and Prevention Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States Disease Control and Prevention Vaccine Sales Market Share in Value by Application (2017-2028)
Figure 37. United States Disease Control and Prevention Vaccine Sales by Application (2017-2028) & (K Units)
Figure 38. United States Disease Control and Prevention Vaccine Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States Disease Control and Prevention Vaccine Price by Application (2017-2028) & (USD/Unit)
Figure 40. North America Disease Control and Prevention Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 41. North America Disease Control and Prevention Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Disease Control and Prevention Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 45. Europe Disease Control and Prevention Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Disease Control and Prevention Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 52. Asia-Pacific Disease Control and Prevention Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Taiwan Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Philippines Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Disease Control and Prevention Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 64. Latin America Disease Control and Prevention Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Disease Control and Prevention Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 69. Middle East & Africa Disease Control and Prevention Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. U.A.E Disease Control and Prevention Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Disease Control and Prevention Vaccine Value Chain
Figure 74. Disease Control and Prevention Vaccine Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs